EGFR and neoplasm: The tumor was negative for epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), ROS proto-oncogene 1 (ROS1) mutations and demonstrated a programmed death-ligand 1 (PD-L1) expression of 60%.